Moderna tops revenue estimates on stronger international COVID vaccine sales

Implied TYLG Analyst Target Price: $44

NASDAQ · Markets 11m ago

Look Under The Hood: SSUS Has 12% Upside

NASDAQ · Markets 11m ago

Exxon beats first-quarter earnings estimate despite hit from Iran conflict

Investing.com · News 12m ago

DTM Crosses Above Average Analyst Target

NASDAQ · Markets 12m ago

Viasat Reaches Analyst Target Price

NASDAQ · Markets 12m ago

PGJ's Underlying Holdings Imply 26% Gain Potential

NASDAQ · Markets 12m ago

APA Reaches Analyst Target Price

NASDAQ · Markets 12m ago

GTX Crosses Above Average Analyst Target

NASDAQ · Markets 12m ago

Glaukos Reaches Analyst Target Price

NASDAQ · Markets 12m ago

Newell Brands beats estimates, raises full year outlook

Investing.com · News 12m ago